MDXGMiMedx Group, Inc.
What is the market doing?
No clear lean: rangebound and moderately shorted.
Rangebound, no clear trend. Oversold (RSI 29). Price is −10% vs its 200-day average.
Moderately shorted, settled Sep 30, 2026, more than a week of normal trading to cover, a crowded exit.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How MDXG is trading
MiMedx Group, Inc. is −42% over the past year while the S&P 500 is +16%: 58 points behind the market.
1-year return · S&P 500 +16%
- vs 200-day average
- −9.7%
vs 200-day average · below trend, but not far
- RSI (14)
- 29
RSI (14) · oversold, sold harder than it has been bought
- Below its 52-week high
- 51%
Below its 52-week high
Details›
- Last close2026-10-23
- $3.91
- 1 monthS&P 500 −0.94%
- −17%
- 1 yearS&P 500 +16%
- −42%
- 5 yearsS&P 500 +86%
- −42%
- vs 50-day average$4.53
- −14%
- 52-week high
- $7.96
- 52-week low
- $3.09
- Annualised volatility
- 45%
| Year | Return |
|---|---|
| 2026 (year to date) | −42% |
| 2025 | −30% |
| 2024 | +9.7% |
| 2023 | +215% |
| 2022 | −54% |
| 2021 | −33% |
| 2020 | +20% |
| 2019 | +323% |
| 2018 | −86% |
| 2017 | +42% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 4 of 10 | +5.3% |
| Feb | 10 | 6 of 10 | −2.6% |
| Mar | 10 | 3 of 10 | −8.6% |
| Apr | 10 | 4 of 10 | −2.2% |
| May | 10 | 7 of 10 | +17% |
| Jun | 10 | 5 of 10 | +4.0% |
| Jul | 11 | 6 of 11 | +4.0% |
| Aug | 11 | 6 of 11 | +6.1% |
| Sep | 11 | 3 of 11 | −8.7% |
| Oct | 11 | 7 of 11 | +1.8% |
| Nov | 10 | 7 of 10 | +6.0% |
| Dec | 10 | 5 of 10 | −1.2% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Where the price stands
Its trend against the 50-day and 200-day averages, and the levels it keeps coming back to.
What it has returned
With dividends, year by year, month by month, and by calendar month on average.